Similarly, mutations in the PTEN tumor suppressor gene disrupt the phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/AKT/mTOR) signaling pathway, yielding a highly immunosuppressive microenvironment. The gene discussed is MTOR; the disease is neoplasm.